Seed and early stage investments in exceptional technology and life sciences companies.
Redbiotec and GE Healthcare Collaborate (30/07/2014)
Redbiotec (Redalpine Capital I), a biopharmaceutical company specializing in vaccine development, has successfully applied its unique expertise and innovative technology platform to complete a collaborative program with global multinational, GE Healthcare Life Sciences. Using GE Healthcare’s single-use WAVE Bioreactor and ReadyToProcess crossflow filtration system, the team developed a novel process for the production, clarification, and [...] More.
Redalpine leads seven-figure funding round for online art platform Juniqe (17/07/2014)
Redalpine is delighted to announce an investment in Berlin-based Juniqe, the up-and-coming e-commerce platform for affordable art. The seven-figure funding round, led by Redalpine with co-investments by High-Tech Gründerfonds, German Startups Group and business angels, will help the company strengthen its international position and accelerate their already impressive growth. There is great demand for affordable [...] More.
InSphero Enters into Collaboration with Protea Biosciences and Wins ‘Startup of the Year’ Award (10/07/2014)
InSphero AG (Redalpine Capital I) and Protea Biosciences Group, Inc. (OTCQB:PRGB) jointly announced that they have entered into a collaboration that will combine each company’s respective 3D technology. InSphero AG is the leading supplier of 3D organotypic microtissues for in vitro toxicology and efficacy studies, with models derived from liver, pancreas, tumor, and brain tissue [...] More.
Google Ventures Opens London Office As A Base For Investing $100M Across Europe (17.07.2014)
Facebook Acquires LiveRail For $400M To $500M To Serve Video Ads Everywhere, Improve Its Own (03.07.2014)
Swiss software company Hulbee AG launches smart and secure search engine (29.06.2014)